RLMD
Relmada Therapeutics, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:59 PM EST
2.86USD-5.150%(-0.15)1,860,822
Pre-marketNov 18, 2026 9:27:30 AM EST
2.88USD-4.319%(-0.13)
After-hoursNov 18, 2026 4:00:30 PM EST
2.855USD0.000%(-0.00)
RLMD Financials
In Q3 FY 2026 (ended ), Relmada Therapeutics, Inc. Common Stock (RLMD) reported net income of −$13.86M, operating cash flow of −$12.59M, and assets of $205.3M (filed ).
Loading financial statements…